10-Q Filing

INTUITIVE SURGICAL INC CIK: 1035267 Q3 2018

Filing Information

Form Type	10-Q
Accession Number	`0001035267-18-000127`
Period End Date	20180930
Filing Date	20181022
Fiscal Year	2018
Fiscal Period	Q3
XBRL Instance	isrg-20180930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 78 Income Statement 72 Cash Flow Statement 66

Balance Sheet 78 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	2.50M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	2.50M	shares	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.01B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$648.20M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$1.31B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$2.13B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$507.90M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$580.40M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Inventory	`InventoryNet`	$241.20M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory	`InventoryNet`	$370.10M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	112.30M	shares	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$166.20M	USD	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$99.20M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	114.20M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$4.25B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	112.30M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	114.20M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$2.81B	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$613.10M	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$746.40M	USD	Point-in-time
Long-term investments	`MarketableSecuritiesNoncurrent`	$1.89B	USD	Point-in-time
Long-term investments	`MarketableSecuritiesNoncurrent`	$1.43B	USD	Point-in-time
Deferred tax assets	`DeferredTaxAssetsNetNoncurrent`	$72.00M	USD	Point-in-time
Deferred tax assets	`DeferredTaxAssetsNetNoncurrent`	$411.50M	USD	Point-in-time
Intangible and other assets, net	`IntangibleAndOtherAssets`	$195.80M	USD	Point-in-time
Intangible and other assets, net	`IntangibleAndOtherAssets`	$237.40M	USD	Point-in-time
Goodwill	`Goodwill`	$201.10M	USD	Point-in-time
Goodwill	`Goodwill`	$236.10M	USD	Point-in-time
Total assets	`Assets`	$7.32B	USD	Point-in-time
Total assets	`Assets`	$5.78B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$82.50M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$96.40M	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$146.10M	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$167.60M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$243.80M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$281.00M	USD	Point-in-time
Other accrued liabilities	`OtherLiabilitiesCurrent`	$179.80M	USD	Point-in-time
Other accrued liabilities	`OtherLiabilitiesCurrent`	$168.90M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$662.80M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$703.30M	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$333.60M	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$326.80M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.03B	USD	Point-in-time
Total liabilities	`Liabilities`	$996.40M	USD	Point-in-time
Contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; no shares issued and outstanding as of September 30, 2018, and December 31, 2017	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; no shares issued and outstanding as of September 30, 2018, and December 31, 2017	`PreferredStockValue`	-	USD	Point-in-time
Common stock, 300.0 shares authorized, $0.001 par value, 114.2 shares and 112.3 shares issued and outstanding as of September 30, 2018, and December 31, 2017, respectively	`CommonStockValue`	$100.00K	USD	Point-in-time
Common stock, 300.0 shares authorized, $0.001 par value, 114.2 shares and 112.3 shares issued and outstanding as of September 30, 2018, and December 31, 2017, respectively	`CommonStockValue`	$100.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$4.68B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$5.06B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.23B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$115.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-15.50M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-16.40M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-9.20M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-8.90M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-9.80M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-16.70M	USD	Point-in-time
Total Intuitive Surgical, Inc. stockholders equity	`StockholdersEquity`	$6.28B	USD	Point-in-time
Total Intuitive Surgical, Inc. stockholders equity	`StockholdersEquity`	$4.78B	USD	Point-in-time
Noncontrolling interest in joint venture	`MinorityInterest`	$1.60M	USD	Point-in-time
Noncontrolling interest in joint venture	`MinorityInterest`	$7.90M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.29B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.78B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$7.32B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$5.78B	USD	Point-in-time

Income Statement 72 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$920.90M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$807.80M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.25B	USD	3 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.68B	USD	3 Qtrs
Total cost of revenue	`CostOfGoodsAndServicesSold`	$678.20M	USD	3 Qtrs
Total cost of revenue	`CostOfGoodsAndServicesSold`	$239.70M	USD	1 Quarter
Total cost of revenue	`CostOfGoodsAndServicesSold`	$809.30M	USD	3 Qtrs
Total cost of revenue	`CostOfGoodsAndServicesSold`	$278.60M	USD	1 Quarter
Gross profit	`GrossProfit`	$1.57B	USD	3 Qtrs
Gross profit	`GrossProfit`	$1.87B	USD	3 Qtrs
Gross profit	`GrossProfit`	$568.10M	USD	1 Quarter
Gross profit	`GrossProfit`	$642.30M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$204.10M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$702.80M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$592.60M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$221.40M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$298.20M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$83.40M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$107.60M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$241.50M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$329.00M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$834.10M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$287.50M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.00B	USD	3 Qtrs
Income from operations	`OperatingIncomeLoss`	$313.30M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$867.40M	USD	3 Qtrs
Income from operations	`OperatingIncomeLoss`	$280.60M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$733.90M	USD	3 Qtrs
Interest and other income, net	`NonoperatingIncomeExpense`	$53.30M	USD	3 Qtrs
Interest and other income, net	`NonoperatingIncomeExpense`	$10.80M	USD	1 Quarter
Interest and other income, net	`NonoperatingIncomeExpense`	$29.60M	USD	3 Qtrs
Interest and other income, net	`NonoperatingIncomeExpense`	$21.90M	USD	1 Quarter
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$335.20M	USD	1 Quarter
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$763.50M	USD	3 Qtrs
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$291.40M	USD	1 Quarter
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$920.70M	USD	3 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$87.00M	USD	3 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-7.20M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$43.40M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$61.10M	USD	3 Qtrs
Net income	`ProfitLoss`	$291.80M	USD	1 Quarter
Net income	`ProfitLoss`	$702.40M	USD	3 Qtrs
Net income	`ProfitLoss`	$298.60M	USD	1 Quarter
Net income	`ProfitLoss`	$833.70M	USD	3 Qtrs
Less: net loss attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: net loss attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.70M	USD	3 Qtrs
Less: net loss attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$-700.00K	USD	1 Quarter
Less: net loss attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	3 Qtrs
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$702.40M	USD	3 Qtrs
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$835.40M	USD	3 Qtrs
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$298.60M	USD	1 Quarter
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$292.50M	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.57	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$6.29	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$7.37	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.67	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.45	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.56	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$7.04	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$6.06	USD	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	111.80M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	111.60M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	114.00M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	113.40M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	115.90M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	116.80M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	119.20M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	118.60M	shares	3 Qtrs
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$834.20M	USD	3 Qtrs
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$292.20M	USD	1 Quarter
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$702.10M	USD	3 Qtrs
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$299.20M	USD	1 Quarter

Cash Flow Statement 66 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$298.60M	USD	1 Quarter
Net income	`ProfitLoss`	$833.70M	USD	3 Qtrs
Net income	`ProfitLoss`	$291.80M	USD	1 Quarter
Net income	`ProfitLoss`	$702.40M	USD	3 Qtrs
Depreciation and loss on disposal of property, plant, and equipment	`Depreciation`	$76.80M	USD	3 Qtrs
Depreciation and loss on disposal of property, plant, and equipment	`Depreciation`	$61.40M	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$10.10M	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$9.70M	USD	3 Qtrs
Loss on investments, accretion of discounts, and amortization of premiums on investments, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-3.20M	USD	3 Qtrs
Loss on investments, accretion of discounts, and amortization of premiums on investments, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-16.80M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$31.40M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$52.30M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$190.80M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$153.50M	USD	3 Qtrs
Amortization of contract acquisition asset	`CapitalizedContractCostAmortization`	$7.90M	USD	3 Qtrs
Amortization of contract acquisition asset	`CapitalizedContractCostAmortization`	$8.20M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$65.20M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$38.70M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$82.70M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$205.80M	USD	3 Qtrs
Prepaids and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$17.80M	USD	3 Qtrs
Prepaids and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$89.30M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$11.90M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$13.40M	USD	3 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-21.50M	USD	3 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-11.30M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$34.70M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$35.80M	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-69.10M	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-9.20M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$811.90M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$831.50M	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireMarketableSecurities`	$1.12B	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireMarketableSecurities`	$1.69B	USD	3 Qtrs
Proceeds from sales of investments	`ProceedsFromSaleOfAvailableForSaleSecurities`	$274.00M	USD	3 Qtrs
Proceeds from sales of investments	`ProceedsFromSaleOfAvailableForSaleSecurities`	$1.53B	USD	3 Qtrs
Proceeds from maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$1.05B	USD	3 Qtrs
Proceeds from maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$450.70M	USD	3 Qtrs
Purchase of property, plant, and equipment and intellectual property	`PaymentsToAcquireProductiveAssets`	$131.90M	USD	3 Qtrs
Purchase of property, plant, and equipment and intellectual property	`PaymentsToAcquireProductiveAssets`	$159.70M	USD	3 Qtrs
Acquisition of businesses, net of cash	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	3 Qtrs
Acquisition of businesses, net of cash	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$60.10M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$694.50M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-563.30M	USD	3 Qtrs
Proceeds from issuance of common stock relating to employee stock plans	`ProceedsFromStockPlans`	$381.60M	USD	3 Qtrs
Proceeds from issuance of common stock relating to employee stock plans	`ProceedsFromStockPlans`	$199.60M	USD	3 Qtrs
Taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$115.00M	USD	3 Qtrs
Taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$53.60M	USD	3 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$2.00B	USD	3 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	3 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$8.00M	USD	3 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$2.00M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.67B	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$92.60M	USD	3 Qtrs
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$2.00M	USD	3 Qtrs
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-700.00K	USD	3 Qtrs
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-161.60M	USD	3 Qtrs
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$360.10M	USD	3 Qtrs
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.02B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$663.20M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$890.00M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.02B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$663.20M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$890.00M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.